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Asthma-Related Anxiety and Quick-Relief Medication
Use in Urban Children with Asthma
Sarah Astrab, Dr. Robin Everhart, Department of Psychology

Introduction

Procedure

 Asthma is an illness that impacts the lungs and is the
most common chronic illness among children.
 Although not curable, asthma is manageable through
proper treatments, including daily controller use and
rescue inhalers.
 Anxiety has been found to increase asthma symptoms
in children (Bruzzese, Unikel, Shrout, & Klein, 2011).
 Caregivers who are anxious about their child’s asthma
symptoms may perceive their child’s symptoms as
more severe and/or doubt their ability to manage their
child’s asthma (Bruzzese et al., 2011). This can result
in the misuse of asthma medication.

 Participants were recruited from the Virginia Commonwealth
University Health System.
 During the initial visit, data were collected in the participant’s home
or in our research office.
 Questionnaires completed by participants included demographic
forms, Parent Asthma-Related Anxiety Scale (PAAS) and Youth
Asthma-Related Anxiety Scale (YAAS), Asthma Control Test, and
reports of current child asthma medications.
 PAAS and YAAS. Children and caregivers rate how frequently they
felt nervous or worried because of asthma during the past 2 weeks
using a six point Likert scale (0=never to 5=always). Higher scores
indicate worse asthma-related anxiety (Bruzzese et al., 2011).
 ACT. Assesses frequency of daytime and nighttime asthma
symptoms, activity limitation, and patient perception of disease
control. Higher scores indicate asthma that is in control (Nathan et al.,
2003).

Goal of Study

Results

This study focused on the association between asthmarelated anxiety and the use of quick-relief asthma
medications in a low-income, urban sample of
children with asthma in Richmond, Virginia.

Participants
Participants included an urban sample of 53 families
who reside in Richmond, Virginia.
Children participating in the study were diagnosed
with asthma by a physician or experienced breathing
problems in the past 12 months.
The age of child participants ranged from 7 to 12
years [M=9.5, (SD) =1.5]; 75% were male.
89% of child participants were African
American/Black and 8% identified as
Caucasian/White. The remaining participants
identified as mixed or multiracial (3%).
85% of primary caregivers were biological mothers,
while 5% were biological fathers. The remaining 10%
of caregivers were grandparents or adoptive parents.
66% of primary caregivers reported to have never been
married, 15% were currently married, 17% reported
being divorced, and 2% reported being widowed.

Discussion

Mean

Standard Deviation

Youth Asthma-Related Anxiety Scale

1.61

.97

Parent Asthma-Related Anxiety Scale

1.10

.86

The Pearson product-moment correlation was used (r=.08,
p=.59). This test showed that there was no statistically
significant correlation between parent asthma-related anxiety
and child asthma-related anxiety.
Days per week of QuickRelief Medication Usage

0-2

Percent of Participants using
Quick-Relief Medication

43%

3-6

Our findings suggest that higher caregiver asthmarelated anxiety may be associated with more child
rescue medication usage. However, this association was
not significant when controlling for asthma control.
These findings are important to consider when looking
at a child with asthma because poor asthma
management could be associated with higher parent
asthma-related anxiety.
If providers are aware of parent and child asthmarelated anxiety levels, they could work with the families
to determine the most appropriate way to approach
asthma management techniques in the context of
disease-specific anxiety.
Our results suggest the importance of focusing on child
anxiety in addition to parent anxiety as children and
parents may be reporting different levels of anxiety
related to asthma.

Every day of the week
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In parents, there was a significant difference in asthma-related
anxiety across number of quick-relief puffs (ANOVA results:
F(2,48)=7.12, p=.002).
Post-hoc Tukey HSD analyses revealed a significant difference
in level of anxiety such that caregivers that reported using
quick-relief medication 0-2 days had lower levels of anxiety
than caregivers using quick-relief medication 3-6 days a week.
The association between child asthma-related anxiety and
number of quick-relief puffs was not significant
(F(2,48)=.016, p=.984).
With asthma control in the model, the association between
parental anxiety and rescue medication usage was no longer
significant (FΔ (1,45)=.699, p=.408).
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